$0.48
0.0452[10.40%]
At close: May 17
$0.48
0[0.00%]
After Hours: 7:26PM EDT
Dare Bioscience
(NASDAQ:DARE)Latest News for Dare Bioscience Stock (NASDAQ:DARE)
Dare Bioscience Stock (NASDAQ: DARE)
Categories: All
Friday, May 17, 2024
Wednesday, May 15, 2024
- HC Wainwright & Co. Reiterates Buy on Dare Bioscience, Maintains $6 Price TargetBenzinga Newsdesk - 3 days ago
- Dare Bioscience shares are trading higher after Brookline Capital upgraded the stock from Hold to Buy and announced a $3 price target.Benzinga Newsdesk - 4 days ago
- Brookline Capital Upgrades Dare Bioscience to Buy, Announces $3 Price TargetBenzinga Newsdesk - 4 days ago
Tuesday, May 14, 2024
Friday, May 10, 2024
Thursday, May 02, 2024
Wednesday, May 01, 2024
Tuesday, April 30, 2024
- Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionAvi Kapoor - Apr 30, 2024, 1:24PM
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Apr 30, 2024, 12:31PM
- Dare Bioscience shares are trading higher after the XOMA acquired an economic interest in the company's women's health assets. Also, the company announced that the transaction allows it to focus on advancing Phase 3 first-in-category women's health product candidates.Benzinga Newsdesk - Apr 30, 2024, 7:47AM
- Xoma Has Acquired An Economic Interest In Three Women's Health Assets From Daré Bioscience For An Upfront Payment Of $22MBenzinga Newsdesk - Apr 30, 2024, 7:36AM
Thursday, April 25, 2024
Wednesday, April 24, 2024
Tuesday, April 23, 2024
Wednesday, April 17, 2024
- Dare Bioscience shares are trading lower after Brookline Capital downgraded the stock from Buy to Hold.Benzinga Newsdesk - Apr 17, 2024, 1:31PM
- Brookline Capital Downgrades Dare Bioscience to HoldBenzinga Newsdesk - Apr 17, 2024, 1:28PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Apr 17, 2024, 12:31PM
Monday, April 01, 2024
Thursday, March 28, 2024
- 12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga Insights - Mar 28, 2024, 4:31PM
- Dare Bioscience Q4 EPS $(0.06) Beats $(0.10) Estimate, Sales $1.81M Beat $1.79M EstimateBenzinga Newsdesk - Mar 28, 2024, 11:15AM
- Recap: Dare Bioscience Q4 EarningsBenzinga Insights - Mar 28, 2024, 10:25AM
- Daré Bioscience Reported FY23 Revenue of $2.8M Vs $2.07M Est, EPS Loss of $(0.35) Vs $(0.38) Est, Cash Balance of $10.5MBenzinga Newsdesk - Mar 28, 2024, 8:11AM
- Earnings Scheduled For March 28, 2024Benzinga Insights - Mar 28, 2024, 5:24AM
Wednesday, March 27, 2024
Tuesday, March 26, 2024
Monday, March 04, 2024
Wednesday, February 21, 2024
Wednesday, January 31, 2024
Friday, January 26, 2024
Wednesday, January 17, 2024
Thursday, January 04, 2024
Wednesday, December 20, 2023
- Daré Bioscience Highlights Efficacy Data From Treatment Candidate For Painful MenstruationVandana Singh - Dec 20, 2023, 12:34PM
- Daré Bioscience Announces Topline Pharmacokinetic And Exploratory Efficacy Results From The DARE-PDM1 Phase 1 Clinical StudyBenzinga Newsdesk - Dec 20, 2023, 8:15AM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Dec 20, 2023, 8:07AM
Wednesday, December 13, 2023
Thursday, December 07, 2023
- FDA Gives Nod To Daré Bioscience's Trial Of Non-Hormonal Treatment For Dyspareunia, Seeks Additional FundingVandana Singh - Dec 7, 2023, 10:01AM
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - Dec 7, 2023, 8:07AM
- Daré Bioscience Announces FDA Clearance Of Investigational New Drug Application For DARE-VVA1Benzinga Newsdesk - Dec 7, 2023, 8:01AM
Monday, December 04, 2023
Friday, November 10, 2023
Thursday, November 09, 2023
Wednesday, November 08, 2023
Monday, October 16, 2023
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga Insights - Oct 16, 2023, 5:31PM
- Dare Bioscience shares are trading higher after the company announced the achievement of its first commercial milestone under license agreement for XACIATO vaginal gel.Benzinga Newsdesk - Oct 16, 2023, 11:59AM